SLC5A4 and hypertensive disorder: Studies on human patients and experimental models reveal specific mechanisms related to programmed hypertension in the kidney, such as reduced nephron number, oxidative stress, epigenetic regulation, activation of the renin–angiotensin system (RAS), and sodium transporters.